​

Tandem Diabetes Care (TNDM) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Tandem Diabetes Care Revenue Highlights

Latest Revenue (Y)

$747.72M

Latest Revenue (Q)

$221.91M

Main Geography (Y)

UNITED STATES

Tandem Diabetes Care Revenue by Period

Tandem Diabetes Care Revenue by Year

DateRevenueChange
2023-12-31$747.72M-6.68%
2022-12-31$801.22M14.00%
2021-12-31$702.80M40.89%
2020-12-31$498.83M37.68%
2019-12-31$362.31M97.05%
2018-12-31$183.87M70.88%
2017-12-31$107.60M27.72%
2016-12-31$84.25M15.65%
2015-12-31$72.85M46.51%
2014-12-31$49.72M71.42%
2013-12-31$29.01M1072.13%
2012-12-31$2.47M100.00%
2011-12-31--

Tandem Diabetes Care generated $747.72M in revenue during NA 2023, up -6.68% compared to the previous quarter, and up 406.66% compared to the same period a year ago.

Tandem Diabetes Care Revenue by Quarter

DateRevenueChange
2024-06-30$221.91M15.77%
2024-03-31$191.67M-2.60%
2023-12-31$196.80M6.02%
2023-09-30$185.62M-5.25%
2023-06-30$195.92M15.67%
2023-03-31$169.38M-23.18%
2022-12-31$220.50M7.80%
2022-09-30$204.55M2.14%
2022-06-30$200.26M13.85%
2022-03-31$175.91M-16.23%
2021-12-31$210.00M16.91%
2021-09-30$179.63M4.35%
2021-06-30$172.14M22.05%
2021-03-31$141.04M-16.08%
2020-12-31$168.06M35.97%
2020-09-30$123.60M13.15%
2020-06-30$109.24M11.55%
2020-03-31$97.93M-9.66%
2019-12-31$108.40M14.52%
2019-09-30$94.66M1.50%
2019-06-30$93.25M41.31%
2019-03-31$66.00M-13.39%
2018-12-31$76.20M64.70%
2018-09-30$46.26M35.57%
2018-06-30$34.13M25.11%
2018-03-31$27.28M-32.31%
2017-12-31$40.29M49.22%
2017-09-30$27.00M26.61%
2017-06-30$21.33M12.38%
2017-03-31$18.98M-34.36%
2016-12-31$28.91M135.19%
2016-09-30$12.29M-46.52%
2016-06-30$22.98M14.59%
2016-03-31$20.06M-31.12%
2015-12-31$29.12M85.29%
2015-09-30$15.72M0.06%
2015-06-30$15.71M27.61%
2015-03-31$12.31M-31.19%
2014-12-31$17.89M32.37%
2014-09-30$13.51M31.78%
2014-06-30$10.25M27.14%
2014-03-31$8.07M-21.27%
2013-12-31$10.24M31.74%
2013-09-30$7.78M40.67%
2013-06-30$5.53M1.27%
2013-03-31$5.46M141.85%
2012-12-31$2.26M936.61%
2012-09-30$217.73K-

Tandem Diabetes Care generated $221.91M in revenue during Q2 2024, up 15.77% compared to the previous quarter, and up 131.01% compared to the same period a year ago.

Tandem Diabetes Care Revenue Breakdown

Tandem Diabetes Care Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24Jun 18Mar 18
Pump$114.80M$107.88M$87.29M--
Supplies and Other$128.13M$113.88M$105.53M--
Complementary Products---$2.30M$2.10M

Tandem Diabetes Care's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Supplies and Other (52.74%), and Pump (47.26%).

Tandem Diabetes Care Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20
Non-US$192.84M$212.45M$177.89M$83.15M
UNITED STATES$554.88M$588.76M$524.91M$415.68M

Tandem Diabetes Care's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (74.21%), and Non-US (25.79%).

Quarterly Revenue by Country

CountrySep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
Non-US$72.32M$65.20M$61.91M$45.88M$55.40M$53.42M$38.14M$54.72M$58.51M$54.59M$44.62M$49.11M$46.52M$44.56M$37.70M
UNITED STATES$171.65M$156.71M$129.76M$150.91M$130.22M$142.50M$131.24M$165.78M$146.03M$145.67M$131.28M$160.88M$133.11M$127.58M$103.34M

Tandem Diabetes Care's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (70.36%), and Non-US (29.64%).

Tandem Diabetes Care Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ABTAbbott Laboratories$40.11B$10.63B
MDTMedtronic$32.36B$8.40B
SYKStryker$20.50B$5.49B
ALGNAlign$3.86B$977.87M
DXCMDexCom$3.62B$994.20M
PODDInsulet$1.70B$372.60M
PENPenumbra$1.06B$301.04M
TNDMTandem Diabetes Care$747.72M$221.91M
INSPInspire Medical Systems$624.80M$203.19M
PACBPacific Biosciences of California$200.52M$38.81M
NNOXNano-X Imaging$9.90M$2.55M

TNDM Revenue FAQ

What is Tandem Diabetes Care’s yearly revenue?

Tandem Diabetes Care's yearly revenue for 2023 was $747.72M, representing a decrease of -6.68% compared to 2022. The company's yearly revenue for 2022 was $801.22M, representing an increase of 14.00% compared to 2021. TNDM's yearly revenue for 2021 was $702.8M, representing an increase of 40.89% compared to 2020.

What is Tandem Diabetes Care’s quarterly revenue?

Tandem Diabetes Care's quarterly revenue for Q2 2024 was $221.91M, a 15.77% increase from the previous quarter (Q1 2024), and a 13.27% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $191.67M, a -2.60% decrease from the previous quarter (Q4 2023), and a 13.16% increase year-over-year (Q1 2023). TNDM's quarterly revenue for Q4 2023 was $196.8M, a 6.02% increase from the previous quarter (Q3 2023), and a -10.75% decrease year-over-year (Q4 2022).

What is Tandem Diabetes Care’s revenue growth rate?

Tandem Diabetes Care's revenue growth rate for the last 3 years (2021-2023) was 6.39%, and for the last 5 years (2019-2023) was 106.38%.